Latest News and Press Releases
Want to stay updated on the latest news?
-
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
-
Los Angeles, USA and Copenhagen, Denmark, Sept. 17, 2025 (GLOBE NEWSWIRE) -- – Eyenuk, a global leader in AI-powered eye screening, today announced that its EyeArt® AI Eye Screening System has been...
-
EyeMD EMR Healthcare Systems Announces Rebrand to Optivate, Signaling Expanded Vision for Ophthalmology Practices and Eye Care Providers
-
ALISO VIEJO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced the appointment of Anand Sundaram as the company’s Vice President,...
-
Upfront fees and near-term development milestone payments totaling up to $7.5 millionPotential sales milestones of $180 million or more in first 10 years of commercializationRoyalties equaling 25% of...
-
PITTSBURGH, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Retina Group of Florida (“RGF”) recently announced a cybersecurity incident, which impacted the personal information of over one hundred fifty thousand...
-
Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "North America Intraocular Lens Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...
-
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and...
-
MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...
-
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01...